Tivic Health Systems, Inc. (VBIO): Insider Trading, Congress Trades & Research | Tormere

VBIO

$0.53+0.00%visit website

Tivic Health Systems, Inc.

Market Cap

$2M

Live price × Finnhub shares (2026-09-24)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.87

59mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	146
Cost of revenue	291
Gross profit	(145)
Research & development	858	1,283	1,854	2,704	6,699
Selling, general & administrative			3,780	3,720
Total operating expenses	2,338	2,016	5,634	6,424	16,412
Operating income	(2,483)	(1,975)	(5,634)	(6,424)	(16,516)
Interest expense			648	691
Net income	(2,596)	(2,849)	(6,202)	(7,103)	(18,750)
EPS (basic) ($)	(1.97)		(2.23)	(2.17)	—
Weighted avg. shares (basic)	1,321		2,884	3,380

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 18 more quarters, back to Mar 2021, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

3i, LP · 2026-09-03

No Form 4 transactions on record.

Recent News

Form 8K Valion Bio Inc For: 2 November By Investing.com

Investing.com Nigeria · 2026-11-02

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga · 2026-10-30

Valion Bio (VBIO) Advances Entolimod Evaluation with AFRRI Study on Radiation Syndrome

GuruFocus · 2026-10-30

Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results

Yahoo · 2026-10-30

Researchers will test whether Valion Bio's drug helps mice survive after radiation exposure.

Stock Titan · 2026-10-30

Valion Bio Announces That The Armed Forces Radiobiology Research Institute Will Evaluate The Therapeutic Efficacy Of Entolimod

Benzinga · 2026-10-30

Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation

Yahoo · 2026-10-28

Valion Bio Announces Final Data From Entolimod Study For Hematopoietic And Gastrointestinal Forms Of Acute Radiation Syndrome; AFRRI Study Found No Evidence Of Treatment-Related Toxicity After One Dose Of Entolimod, Supporting Advancement Toward A Fully Funded Therapeutic Study

Benzinga · 2026-10-28

Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-27

Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options

Yahoo · 2026-10-26

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga · 2026-10-26

Valion Bio Confirms Receipt Of Proposed Acquisition Offers For Its Velocity Bioworks; Terms Undisclosed

Benzinga · 2026-10-26

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 2026-10-22

Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value

Yahoo · 2026-10-21

Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone

Yahoo · 2026-10-15

Informational purposes only, not investment advice.

Corporate Events (8-K)

4 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 7:50 AM ET	5.02Officer / director change8.01Other events	Document SEC ↗
Oct 29, 2026 accepted 7:45 AM ET	8.01Other events	Document SEC ↗
Oct 27, 2026 accepted 6:01 AM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Oct 26, 2026 accepted 8:00 AM ET	8.01Other events	Document SEC ↗